Noel R. Wallace Sells 4,541 Shares of Colgate-Palmolive (CL) Stock

Colgate-Palmolive (NYSE:CL) COO Noel R. Wallace sold 4,541 shares of the business’s stock in a transaction on Tuesday, February 19th. The shares were sold at an average price of $66.43, for a total transaction of $301,658.63. Following the sale, the chief operating officer now directly owns 186,380 shares of the company’s stock, valued at $12,381,223.40. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

Shares of CL stock traded up $0.03 during trading on Friday, reaching $66.73. The company’s stock had a trading volume of 3,041,964 shares, compared to its average volume of 4,431,916. The firm has a market cap of $57.69 billion, a PE ratio of 22.47, a P/E/G ratio of 4.30 and a beta of 0.78. Colgate-Palmolive has a one year low of $57.41 and a one year high of $72.61.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, January 25th. The company reported $0.74 EPS for the quarter, topping the Zacks’ consensus estimate of $0.73 by $0.01. The business had revenue of $3.81 billion for the quarter, compared to analyst estimates of $3.78 billion. Colgate-Palmolive had a net margin of 15.44% and a return on equity of 25,268.29%. The firm’s revenue for the quarter was down 2.1% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.75 earnings per share. As a group, equities analysts predict that Colgate-Palmolive will post 2.83 EPS for the current year.



The company also recently announced a quarterly dividend, which was paid on Friday, February 15th. Investors of record on Wednesday, January 23rd were issued a dividend of $0.42 per share. The ex-dividend date of this dividend was Tuesday, January 22nd. This represents a $1.68 dividend on an annualized basis and a yield of 2.52%. Colgate-Palmolive’s payout ratio is 56.57%.

CL has been the subject of several research analyst reports. Citigroup reduced their price target on shares of Colgate-Palmolive from $68.00 to $63.00 and set a “hold” rating for the company in a research report on Monday, October 29th. Argus cut their price target on shares of Colgate-Palmolive from $75.00 to $70.00 and set a “buy” rating on the stock in a research note on Tuesday, October 30th. Goldman Sachs Group raised shares of Colgate-Palmolive from a “neutral” rating to a “buy” rating in a research report on Tuesday, January 8th. JPMorgan Chase & Co. lowered shares of Colgate-Palmolive from a “neutral” rating to an “underweight” rating and cut their price objective for the stock from $61.00 to $54.00 in a research report on Monday, October 29th. Finally, BNP Paribas raised shares of Colgate-Palmolive from an “underperform” rating to a “neutral” rating and boosted their price objective for the stock from $56.00 to $67.00 in a research report on Monday, February 11th. Two analysts have rated the stock with a sell rating, twelve have issued a hold rating and four have given a buy rating to the company. Colgate-Palmolive currently has a consensus rating of “Hold” and an average price target of $65.13.

Institutional investors and hedge funds have recently modified their holdings of the stock. Capital Financial Planning LLC acquired a new position in Colgate-Palmolive during the fourth quarter worth $27,000. Parisi Gray Wealth Management increased its holdings in Colgate-Palmolive by 365.3% during the fourth quarter. Parisi Gray Wealth Management now owns 470 shares of the company’s stock worth $28,000 after buying an additional 369 shares during the last quarter. Timber Creek Capital Management LLC increased its holdings in Colgate-Palmolive by 247.1% during the fourth quarter. Timber Creek Capital Management LLC now owns 472 shares of the company’s stock worth $28,000 after buying an additional 336 shares during the last quarter. Portfolio Solutions LLC acquired a new position in Colgate-Palmolive during the fourth quarter worth $30,000. Finally, Lindbrook Capital LLC acquired a new position in Colgate-Palmolive during the fourth quarter worth $36,000. Institutional investors and hedge funds own 75.42% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This piece was first posted by Dakota Financial News and is owned by of Dakota Financial News. If you are accessing this piece on another domain, it was copied illegally and reposted in violation of US & international copyright laws. The correct version of this piece can be read at https://dakotafinancialnews.com/2019/02/22/noel-r-wallace-sells-4541-shares-of-colgate-palmolive-cl-stock.html.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. It operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The company offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; personal care products comprising bar and liquid hand soaps, shower gels, shampoos, conditioners, and deodorants and antiperspirants; and home care products, such as laundry and dishwashing detergents, fabric conditioners, household cleaners, and other related products.

Recommended Story: What is the Dividend Aristocrat Index?

Insider Buying and Selling by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.